Monthly Archives: July 2015

The Venture Funding Boom In Biotech: A Few Things It’s Not
July 23, 2015

Venture-backed biotechs continue their blistering pace of funding. According to the latest MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), with data from Thomson Reuters, over $2.1B was invested in biotech companies in 2Q 2015, bringing the year

Leave a comment

Storming The Beach: De-risking Novel Modalities Through Innovative Translational Medicine
July 21, 2015

This blog was written by Bill Marshall, co-founder and CEO of miRagen Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. microRNAs are an exciting new class of gene regulatory molecules that act on systems biology, and their modulation

Leave a comment

Volatile Mixture: Young Biotechs’ Stock Market Rollercoaster
July 10, 2015

The stock market has been a wild ride of late – big moves up and down, NYSE getting halted, Grexit, China – lots of reasons for added skittishness. The VIX index, which measures the volatility of the S&P500, has gone